Discovery is the key to advancing human health. Find out how our leading researchers are pioneering new, breakthrough solutions to some of the world’s most challenging health problems.
The $2.2-million drug discovery partnership with the B.C.-based biotech company will explore using diverse fungi for medicinal purposes, and will facilitate the large-scale production of any leads.
Led by CEO John Valliant, the company that develops next-generation precision cancer medicines will become a wholly owned subsidiary of AstraZeneca and continue its operations at its state-of-the-art facility at McMaster Innovation Park.
McMaster researcher John Eikelboom co-leads the pan-African REVIVE trial, which will test a low-cost antibiotic as an effective tool to address the HIV crisis in Africa.
McMaster logo
